Tilray medical announces scientific study on medical cannabis for patients over age 50

Berlin, july 09, 2024 (globe newswire) -- tilray medical, a division of tilray brands, inc. ("tilray") (nasdaq: tlry; tsx: tlry) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a new tilray-led scientific publication titled, medical cannabis for patients over age 50: a multi-site, prospective study of patterns of use and health outcomes. the medical cannabis in older patients study (“mcops”) is a multi-site, prospective, observational study examining the real-world impact of medical use on patients over the age of 50 and under the guidance of a healthcare provider.
TLRY Ratings Summary
TLRY Quant Ranking